STUDIES ON REGIONAL PERFUSION AND INTRA-ARTERIAL INFUSION FOR CANCER CHEMOTHERAPY.
D000970:Antineoplastic Agents; D001943:Breast Neoplasms; D002445:Celiac Artery; D010478:Chemotherapy, Cancer, Regional Perfusion; D003110:Colonic Neoplasms; D003397:Craniopharyngioma; D005260:Female; D006801:Humans; D007261:Infusions, Intra-Arterial; D007263:Infusions, Parenteral; D008080:Liposarcoma; D008113:Liver Neoplasms; D016403:Lymphoma, Large B-Cell, Diffuse; D008228:Lymphoma, Non-Hodgkin; D008466:Mechlorethamine; D016685:Mitomycin; D009217:Myosarcoma; D009362:Neoplasm Metastasis; D009369:Neoplasms; D012516:Osteosarcoma; D010911:Pituitary Neoplasms; D012004:Rectal Neoplasms; D012509:Sarcoma; D012878:Skin Neoplasms; D013274:Stomach Neoplasms; D013964:Thyroid Neoplasms; D014594:Uterine Neoplasms
D000970:Antineoplastic Agents; D008466:Mechlorethamine; D016685:Mitomycin
ANTINEOPLASTIC AGENTS; BREAST NEOPLASMS; CELIAC ARTERY; COLONIC NEOPLASMS; CRANIOPHARYNGIOMA; INFUSIONS, PARENTERAL; ISOLATION PERFUSION; LIPOSARCOMA; LIVER NEOPLASMS; MECHLORETHAMINE OXIDE; MITOMYCIN; MYOSARCOMA; NEOPLASM METASTASIS; RECTAL NEOPLASMS; SARCOMA, OSTEOGENIC; SARCOMA, RETICULUM CELL; SKIN NEOPLASMS; STOMACH NEOPLASMS; THYROID NEOPLASMS; UTERINE NEOPLASMS